Scarica l'app Stockscreener
21.44
0.19%
0.04
Precedente Chiudi:
$21.40
Aprire:
$21.22
Volume 24 ore:
1.24M
Relative Volume:
0.74
Capitalizzazione di mercato:
$1.89B
Reddito:
$1.13B
Utile/perdita netta:
$62.75M
Rapporto P/E:
34.03
EPS:
0.63
Flusso di cassa netto:
$170.92M
1 W Prestazione:
-3.68%
1M Prestazione:
+2.53%
6M Prestazione:
+28.54%
1 anno Prestazione:
-34.53%
Intervallo 1D:
$20.63
$21.56
Intervallo di 1 settimana:
$20.63
$22.81
Portata 52W:
$13.39
$33.84
Progyny Inc Stock (PGNY) Company Profile
Nome
Progyny Inc
Settore
Industria
Telefono
212-888-3124
Indirizzo
1359 BROADWAY, NEW YORK, NY
Confronta PGNY con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
21.44 | 1.89B | 1.13B | 62.75M | 170.92M | 0.63 |
|
UNH
Unitedhealth Group Inc
|
454.11 | 536.99B | 400.28B | 14.41B | 20.71B | 15.50 |
|
ELV
Elevance Health Inc
|
424.53 | 99.88B | 176.81B | 5.98B | 4.55B | 25.61 |
|
CI
Cigna Group
|
330.13 | 89.25B | 244.38B | 3.43B | 8.96B | 12.24 |
|
CVS
Cvs Health Corp
|
67.29 | 87.36B | 372.81B | 4.61B | 6.33B | 3.66 |
|
HUM
Humana Inc
|
264.48 | 34.38B | 117.76B | 1.21B | 2.39B | 9.95 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-02 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-11-13 | Downgrade | Truist | Buy → Hold |
| 2024-09-19 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-07 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-08-07 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2024-08-07 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-07-16 | Iniziato | JMP Securities | Mkt Outperform |
| 2024-05-10 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-09-27 | Iniziato | Canaccord Genuity | Buy |
| 2023-05-22 | Iniziato | BTIG Research | Buy |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-01-05 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2022-09-07 | Iniziato | Truist | Buy |
| 2021-12-02 | Iniziato | Jefferies | Buy |
| 2021-11-22 | Downgrade | Citigroup | Buy → Neutral |
| 2021-09-30 | Iniziato | Berenberg | Buy |
| 2021-08-12 | Iniziato | Barclays | Overweight |
| 2021-06-02 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-04-29 | Ripresa | JP Morgan | Overweight |
| 2021-03-10 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-07-01 | Iniziato | SVB Leerink | Outperform |
| 2020-06-02 | Iniziato | Guggenheim | Buy |
| 2019-11-19 | Iniziato | Citigroup | Buy |
| 2019-11-19 | Iniziato | Goldman | Buy |
| 2019-11-19 | Iniziato | JP Morgan | Overweight |
| 2019-11-19 | Iniziato | Piper Jaffray | Overweight |
| 2019-11-19 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Progyny Inc Borsa (PGNY) Ultime notizie
Returns Are Gaining Momentum At Progyny (NASDAQ:PGNY) - Yahoo Finance
Progyny names new COO and CPO to drive growth By Investing.com - Investing.com India
Progyny (PGNY) Boosts Leadership Team with COO and Chief Product Officer Appointments | PGNY Stock News - GuruFocus
Progyny Names Melissa Cummings COO - MarketScreener
Progyny names new COO and CPO to drive growth - Investing.com
Progyny Names Healthcare Veterans Melissa Cummings as Chief Operating Officer and Geoffrey Clapp as Chief Product Officer | PGNY Stock News - GuruFocus
Progyny Names Healthcare Veterans Melissa Cummings as Chief Operating Officer and Geoffrey Clapp as Chief Product Officer - Yahoo Finance
Progyny to Host Events Honoring Individuals, Families and Infert - GuruFocus
Progyny to Host Events Honoring Individuals, Families and - GlobeNewswire
Progyny Takes Over Nasdaq & Empire State Building for Groundbreaking Fertility Awareness Week - Stock Titan
Progyny announces director Dr. Fred Cohen to step down By Investing.com - Investing.com Canada
Form DEFA14A Progyny, Inc. - StreetInsider
Progyny announces director Dr. Fred Cohen to step down - Investing.com Australia
Progyny Director Fred Cohen to Step Down - TipRanks
SEC Form DEFA14A filed by Progyny Inc. - Quantisnow
Progyny, Inc. Announces Fred E. Cohen Notifies the Board of Directors of His Decision Not to Stand for Reelection At the 2025 Annual Meeting of Stockholders - MarketScreener
Assisted Reproductive Technology Market Forecast Report and Company Analysis 2025-2033 Featuring Thermo Fisher Scientific, Sumitomo Mitsui, CooperSurgical, Fujifilm, Merck, Progyny, Cosmos BiomedicalResearchAndMarkets.com - Bluefield Daily Telegraph
The Broken Brown Egg and Progyny Announce the 2025 Awareness, Hope, and Activism Grant™ to Support BIPOC Individuals and Couples in Family Building - The Manila Times
The Broken Brown Egg and Progyny Announce the 2025 - GlobeNewswire
Major Fertility Support: Progyny's New Grant Removes Barriers for BIPOC Family Building - Stock Titan
Progyny's SWOT analysis: fertility benefits provider faces growth hurdles - Investing.com
Progyny, Inc.'s (NASDAQ:PGNY) Stock's On An Uptrend: Are Strong Financials Guiding The Market? - simplywall.st
Progyny (PGNY): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
Progyny, Inc. Reports Strong 2024 Earnings with Optimistic Outlook - MSN
BTIG Upgrades Progyny (PGNY) - Nasdaq
Progyny expands maternal health offerings with doula services By Investing.com - Investing.com South Africa
Analyst Expectations For Progyny's Future - Benzinga
Progyny expands maternal health offerings with doula services - Investing.com India
Progyny expands materna health support with doula services - TipRanks
BTIG lifts Progyny stock rating to Buy, sets $28 target By Investing.com - Investing.com Canada
Progyny Expands Maternal Health Support with Addition of Doula Services - The Manila Times
BTIG lifts Progyny stock rating to Buy, sets $28 target - Investing.com Australia
BTIG Upgrades Progyny to Buy From Neutral, Price Target is $28 - MarketScreener
BTIG upgrades Progyny to Buy on improving demand - TipRanks
The past three years for Progyny (NASDAQ:PGNY) investors has not been profitable - Yahoo Finance
Commit To Buy Progyny At $17.50, Earn 12.7% Annualized Using Options - Nasdaq
James Hardie Industries, MINISO Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Progyny Clears Key Benchmark, Hitting 80-Plus RS Rating - MSN
The three-year loss for Progyny (NASDAQ:PGNY) shareholders likely driven by its shrinking earnings - simplywall.st
Progyny at KeyBanc Forum: Strategic Growth and Challenges By Investing.com - Investing.com UK
How the (PGNY) price action is used to our Advantage - Stock Traders Daily
Progyny Expands Family Building Solutions with New Parent and Child Well-being Offering - GlobeNewswire
Progyny launches Parent and Child Well-being Offering - TipRanks
Progyny Tackles 40% of Workforce Needs with Game-Changing Parent Support Solution - StockTitan
Mutual of America Capital Management LLC Has $194,000 Stock Position in Progyny, Inc. (NASDAQ:PGNY) - Defense World
Progyny at Leerink’s Global Healthcare Conference: Strategic Expansion Focus By Investing.com - Investing.com Canada
Progyny, Inc. to Participate in Upcoming Investor Conferences - The Manila Times
Exclusive Access: Progyny Leadership Reveals Growth Strategy at Triple Healthcare Conference Series - StockTitan
Amalgamated Bank Sells 1,468 Shares of Progyny, Inc. (NASDAQ:PGNY) - Defense World
Truist Financial Corp Cuts Holdings in Progyny, Inc. (NASDAQ:PGNY) - Defense World
Decoding Progyny Inc (PGNY): A Strategic SWOT Insight - GuruFocus
Progyny Inc Azioni (PGNY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Progyny Inc Azioni (PGNY) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Anevski Peter | CHIEF EXECUTIVE OFFICER |
Dec 23 '24 |
Buy |
14.48 |
209,500 |
3,034,084 |
441,463 |
2.59%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):